Page last updated: 2024-08-17

aspartic acid and Mucositis, Oral

aspartic acid has been researched along with Mucositis, Oral in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ1
Benjamin, RS; Bodey, GP; Kurzrock, R; Papdopoulos, N; Plager, C; Valdivieso, M; Yap, BS1
Creagan, ET; Kovach, JS; O'Connell, MJ1
Colofiore, J; Kemeny, N; Martin, D; Sawyer, R; Schneider, A; Seiter, K; Williams, L1
Chabner, BA; Cohen, MH; Erlichman, C; Hubbard, SM; Levine, AS; McAvoy, LM; Strong, JM; Wiernik, PH1

Trials

1 trial(s) available for aspartic acid and Mucositis, Oral

ArticleYear
Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.
    Cancer treatment reports, 1983, Volume: 67, Issue:12

    Topics: Adult; Aged; Alanine; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Nausea; Phosphonoacetic Acid; Rectal Neoplasms; Stomatitis

1983

Other Studies

4 other study(ies) available for aspartic acid and Mucositis, Oral

ArticleYear
Phase II evaluation of PALA in patients with refractory metastatic sarcomas.
    American journal of clinical oncology, 1984, Volume: 7, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Aspartic Acid; Bone Neoplasms; Diarrhea; Drug Evaluation; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Sarcoma; Skin Diseases; Soft Tissue Neoplasms; Stomatitis

1984
A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer.
    Cancer, 1983, Aug-15, Volume: 52, Issue:4

    Topics: Alanine; Aspartic Acid; Diarrhea; Digestive System Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Injections, Intravenous; Organophosphorus Compounds; Phosphonoacetic Acid; Stomatitis

1983
Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin.
    Cancer, 1993, Mar-01, Volume: 71, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Diarrhea; Drug Synergism; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Mouth Mucosa; Neoplasms; Phosphonoacetic Acid; Stomatitis; Uridine

1993
Phase I trial of N-(phosphonacetyl)-L-aspartate.
    Cancer research, 1979, Volume: 39, Issue:10

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Colonic Neoplasms; Diarrhea; Drug Eruptions; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Phosphonoacetic Acid; Remission, Spontaneous; Stomatitis

1979